ELK1 was found to be crucial in successful EGFR signaling, and the study also reported a positive correlation of ELK1’s and MCL1’s expression levels in BC tumors, further reinforcing the TF’s role in tumor progression and aggressiveness [71]. Here, EGFR is linked to breast cancer.